Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: SPR THERAPEUTICS, INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2018-09-24 to 2022-12-22
Current total value of award: $1527167.51
Description: DHA SBIR PHASE II ENHANCEMENT FOR NON-OPIOID PAIN RELIEF